🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchOrforglipron ATTAIN-4 — my results so far Page 6

Orforglipron ATTAIN-4 — my results so far

roxy_nash Sat, Jul 12, 2025 at 6:46 AM 43 replies 2,076 viewsPage 6 of 9
LipidDoc_ATL
Senior Member
1,123
5,678
Apr 2024
Atlanta, GA
Sep 21, 2025 at 11:39 PM#26

From the other side of the consultation, briefly. The distinction that resolves most of these threads is between what is true on average and what is true for one person. Both are real; they answer different questions and get quoted as if they were the same one.

45 18rachel_ABQ, traveltech_sara, AttorneyGrant and 42 others
Reply Quote Save Share Report
BiostatsBrad
Member
456
2,345
Jul 2024
Durham, NC
Oct 1, 2025 at 1:54 PM#27
LipidDoc_ATL said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Can confirm. Same sequence, different timescale. The detail I would add is minor and it is already implied above.

Last edited: Oct 1, 2025 at 2:54 PM
46 19Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 43 others
Reply Quote Save Share Report
jim_asheville
Member
289
1,234
Aug 2024
Asheville, NC
Oct 11, 2025 at 4:14 AM#28
LipidDoc_ATL said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Adding the part of the answer the thread has not reached. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

47 20NurseAsh_DET, BenResearch_OR, MikeKY_noInsulin and 44 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
HPLC_Greg
Senior Member
1,890
8,901
Feb 2024
Research Triangle, NC
Oct 20, 2025 at 6:40 PM#29

Adding the numbers, since they settle part of this. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

Last edited: Oct 21, 2025 at 12:40 AM
48 21Dr.MetabolicMD, RetaRick_CA, JenPlateau and 45 others
Reply Quote Save Share Report
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Oct 30, 2025 at 9:11 AM#30

Closing the loop on my own question.

Resolved, and the thing that resolved it was the least interesting suggestion in the thread. Writing that down for the next person who wants the interesting answer.

Last edited: Oct 30, 2025 at 3:11 PM
20 18kim_atl_prep, sarah_TO, wendy_avl and 17 others
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register